{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:24:53Z","timestamp":1772803493266,"version":"3.50.1"},"reference-count":61,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T00:00:00Z","timestamp":1501718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"eMOOD (AU Ideas Initiative)"},{"name":"Conselho Nacional de Pesquisa \u2013 CNPq","award":["PDE - 203647\/2014-9"],"award-info":[{"award-number":["PDE - 203647\/2014-9"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0182698","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T18:03:30Z","timestamp":1501783410000},"page":"e0182698","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["ZL006, a small molecule inhibitor of PSD-95\/nNOS interaction, does not induce antidepressant-like effects in two genetically predisposed rat models of depression and control animals"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2387-2947","authenticated-orcid":true,"given":"Sandra","family":"Tillmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitor Silva","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico","family":"Liebenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Karina","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregers","family":"Wegener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,8,3]]},"reference":[{"issue":"23","key":"ref1","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)","volume":"289","author":"RC Kessler","year":"2003","journal-title":"Jama"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.euroneuro.2011.08.008","article-title":"Cost of disorders of the brain in Europe 2010","volume":"21","author":"A Gustavsson","year":"2011","journal-title":"European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1468-1331.2011.03590.x","article-title":"The economic cost of brain disorders in Europe","volume":"19","author":"J Olesen","year":"2012","journal-title":"Eur J Neurol"},{"key":"ref4","unstructured":"World Health Organization. The global burden of disease: 2004 update Geneva, Switzerland2008 [cited 2016 19-02-2016]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/healthinfo\/global_burden_disease\/GBD_report_2004update_full.pdf?ua=1\" xlink:type=\"simple\">http:\/\/www.who.int\/healthinfo\/global_burden_disease\/GBD_report_2004update_full.pdf?ua=1<\/ext-link>."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1192\/bjp.178.3.234","article-title":"Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors","volume":"178","author":"ME Thase","year":"2001","journal-title":"The British journal of psychiatry: the journal of mental science"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pharmthera.2006.07.002","article-title":"Differentiating antidepressants of the future: efficacy and safety","volume":"113","author":"S Rosenzweig-Lipson","year":"2007","journal-title":"Pharmacol Ther"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrd2462","article-title":"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders","volume":"7","author":"G Sanacora","year":"2008","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"RM Berman","year":"2000","journal-title":"Biological psychiatry"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1176\/appi.ajp.163.1.153","article-title":"A double-blind, placebo-controlled study of memantine in the treatment of major depression","volume":"163","author":"CA Zarate Jr","year":"2006","journal-title":"The American journal of psychiatry"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.31887\/DCNS.2014.16.1\/rduman","article-title":"Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections","volume":"16","author":"RS Duman","year":"2014","journal-title":"Dialogues Clin Neurosci"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/npp.2013.57","article-title":"Small-molecule inhibitors at the PSD-95\/nNOS interface have antidepressant-like properties in mice","volume":"38","author":"MV Doucet","year":"2013","journal-title":"Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/npp.2013.195","article-title":"Abnormalities in white matter microstructure associated with chronic ketamine use","volume":"39","author":"R Edward Roberts","year":"2014","journal-title":"Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fnana.2013.00023","article-title":"Brain damages in ketamine addicts as revealed by magnetic resonance imaging","volume":"7","author":"C Wang","year":"2013","journal-title":"Front Neuroanat"},{"issue":"Pt 3","key":"ref14","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/bj3570593","article-title":"Nitric oxide synthases: structure, function and inhibition","volume":"357","author":"WK Alderton","year":"2001","journal-title":"Biochem J"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3390\/ph3010273","article-title":"Nitric Oxide Synthase Inhibitors as Antidepressants","volume":"3","author":"G Wegener","year":"2010","journal-title":"Pharmaceuticals"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.euroneuro.2010.07.011","article-title":"Involvement of NMDA receptors and L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effects of escitalopram in the forced swimming test","volume":"20","author":"AD Zomkowski","year":"2010","journal-title":"European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.pbb.2012.09.011","article-title":"The role of the NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of duloxetine in the forced swimming test","volume":"103","author":"AD Zomkowski","year":"2012","journal-title":"Pharmacology, biochemistry, and behavior"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.brainresbull.2016.03.004","article-title":"Involvement of NMDA receptors and L-arginine\/nitric oxide\/cyclic guanosine monophosphate pathway in the antidepressant-like effects of topiramate in mice forced swimming test","volume":"122","author":"S Ostadhadi","year":"2016","journal-title":"Brain research bulletin"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.biopha.2016.05.035","article-title":"Pharmacological evidence for the involvement of the NMDA receptor and nitric oxide pathway in the antidepressant-like effect of lamotrigine in the mouse forced swimming test","volume":"82","author":"S Ostadhadi","year":"2016","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"ref20","first-page":"765","article-title":"Melatonin, Neuroprotective Agents and Antidepressant Therapy","author":"G Wegener","year":"2016"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1017\/neu.2014.39","article-title":"Nitric oxide involvement in the antidepressant-like effect of ketamine in the Flinders sensitive line rat model of depression","volume":"27","author":"N Liebenberg","year":"2015","journal-title":"Acta Neuropsychiatr"},{"issue":"1\u20133","key":"ref22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0165-0327(00)00164-6","article-title":"Elevated plasma nitrate levels in depressive states","volume":"63","author":"E Suzuki","year":"2001","journal-title":"Journal of affective disorders"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.niox.2011.02.002","article-title":"Nitric oxide and major depression","volume":"24","author":"A Dhir","year":"2011","journal-title":"Nitric Oxide"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pbb.2008.10.013","article-title":"Effects of neuronal and inducible NOS inhibitor 1-[2-(trifluoromethyl) phenyl] imidazole (TRIM) in unpredictable chronic mild stress procedure in mice","volume":"92","author":"O Mutlu","year":"2009","journal-title":"Pharmacology, biochemistry, and behavior"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pbb.2010.02.006","article-title":"Involvement of serotonin receptor subtypes in the antidepressant-like effect of TRIM in the rat forced swimming test","volume":"95","author":"G Ulak","year":"2010","journal-title":"Pharmacology, biochemistry, and behavior"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0896-6273(00)80439-0","article-title":"CAPON: a protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95","volume":"20","author":"SR Jaffrey","year":"1998","journal-title":"Neuron"},{"issue":"12","key":"ref27","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/nm.2245","article-title":"Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95","volume":"16","author":"L Zhou","year":"2010","journal-title":"Nature medicine"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbr.2016.02.021","article-title":"Source memory in rats is impaired by an NMDA receptor antagonist but not by PSD95-nNOS protein-protein interaction inhibitors","volume":"305","author":"AE Smith","year":"2016","journal-title":"Behavioural brain research"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0149-7634(05)80230-1","article-title":"The Flinders sensitive line rats: a genetic animal model of depression","volume":"17","author":"DH Overstreet","year":"1993","journal-title":"Neuroscience and biobehavioral reviews"},{"issue":"4\u20135","key":"ref30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neubiorev.2005.03.015","article-title":"The Flinders Sensitive Line rat: a selectively bred putative animal model of depression","volume":"29","author":"DH Overstreet","year":"2005","journal-title":"Neuroscience and biobehavioral reviews"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1124\/pr.111.005397","article-title":"The flinders sensitive line rat model of depression\u201425 years and still producing","volume":"65","author":"DH Overstreet","year":"2013","journal-title":"Pharmacological reviews"},{"issue":"11","key":"ref32","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/sj.mp.4001345","article-title":"Selectively bred Wistar-Kyoto rats: an animal model of depression and hyper-responsiveness to antidepressants","volume":"8","author":"CC Will","year":"2003","journal-title":"Molecular psychiatry"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0031-9384(98)00298-4","article-title":"Behavioral effects of acute and chronic fluoxetine in Wistar-Kyoto rats","volume":"67","author":"G Griebel","year":"1999","journal-title":"Physiology & behavior"},{"issue":"2\u20133","key":"ref34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0014-2999(97)01276-4","article-title":"Are Wistar-Kyoto rats a genetic animal model of depression resistant to antidepressants?","volume":"337","author":"A Lahmame","year":"1997","journal-title":"European journal of pharmacology"},{"issue":"75","key":"ref35","first-page":"e50326","article-title":"Direct intraventricular delivery of drugs to the rodent central nervous system","author":"SL DeVos","year":"2013","journal-title":"Journal of visualized experiments: JoVE"},{"key":"ref36","article-title":"The Rat Brain in Stereotaxic Coordinates","author":"G Paxinos","year":"2007"},{"key":"ref37","first-page":"1","article-title":"Mood and Anxiety Related Phenotypes in Mice. Neuromethods","volume":"42","author":"T Gould","year":"2009"},{"issue":"6\u20137","key":"ref38","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00008877-199711000-00010","article-title":"The forced swimming test as a model for core and component behavioral effects of antidepressant drugs","volume":"8","author":"I Lucki","year":"1997","journal-title":"Behavioural pharmacology"},{"issue":"6","key":"ref39","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nprot.2012.044","article-title":"Using the rat forced swim test to assess antidepressant-like activity in rodents","volume":"7","author":"DA Slattery","year":"2012","journal-title":"Nature protocols"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"L Steru","year":"1985","journal-title":"Psychopharmacology"},{"issue":"6","key":"ref41","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/j.1476-5381.2011.01489.x","article-title":"Antidepressant-like effect induced by systemic and intra-hippocampal administration of DNA methylation inhibitors","volume":"164","author":"AJ Sales","year":"2011","journal-title":"British journal of pharmacology"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pnpbp.2007.07.027","article-title":"Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus","volume":"32","author":"LS Garcia","year":"2008","journal-title":"Progress in neuro-psychopharmacology & biological psychiatry"},{"issue":"4","key":"ref43","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0885-3924(00)00194-9","article-title":"Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study","volume":"20","author":"S Mercadante","year":"2000","journal-title":"Journal of pain and symptom management"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"595141","DOI":"10.5402\/2012\/595141","article-title":"Comparative evaluation of forced swim test and tail suspension test as models of negative symptom of schizophrenia in rodents","volume":"2012","author":"M Chatterjee","year":"2012","journal-title":"ISRN psychiatry"},{"issue":"4\u20135","key":"ref45","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"JF Cryan","year":"2005","journal-title":"Neuroscience and biobehavioral reviews"},{"issue":"2\u20133","key":"ref46","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0091-3057(01)00599-8","article-title":"Intra- and interstrain differences in models of &quot;behavioral despair&quot;","volume":"70","author":"F Bai","year":"2001","journal-title":"Pharmacology, biochemistry, and behavior"},{"issue":"5","key":"ref47","first-page":"567","article-title":"Pharmacokinetics of ketamine and xylazine in young and old Sprague-Dawley rats","volume":"52","author":"D Veilleux-Lemieux","year":"2013","journal-title":"Journal of the American Association for Laboratory Animal Science: JAALAS"},{"issue":"11","key":"ref48","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2460\/ajvr.72.11.1505","article-title":"Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans","volume":"72","author":"LD Mossner","year":"2011","journal-title":"American journal of veterinary research"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fnbeh.2015.00335","article-title":"Exploring Female Mice Interstrain Differences Relevant for Models of Depression","volume":"9","author":"D de Sa-Calcada","year":"2015","journal-title":"Frontiers in behavioral neuroscience"},{"issue":"12","key":"ref50","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/nm.2245","article-title":"Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95","volume":"16","author":"L Zhou","year":"2010","journal-title":"Nature medicine"},{"issue":"9","key":"ref51","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.bmcl.2016.03.074","article-title":"Metabolic investigation on ZL006 for the discovery of a potent prodrug for the treatment of cerebral ischemia","volume":"26","author":"D Chen","year":"2016","journal-title":"Bioorganic & medicinal chemistry letters"},{"issue":"4","key":"ref52","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1046\/j.1471-4159.1996.66041683.x","article-title":"Ex vivo measurement of brain tissue nitrite and nitrate accurately reflects nitric oxide synthase activity in vivo","volume":"66","author":"M Salter","year":"1996","journal-title":"Journal of neurochemistry"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/0006-291X(90)92382-A","article-title":"Regional distribution of EDRF\/NO-synthesizing enzyme(s) in rat brain","volume":"168","author":"U Forstermann","year":"1990","journal-title":"Biochemical and biophysical research communications"},{"issue":"15","key":"ref54","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1097\/00001756-199410000-00039","article-title":"Time course of inhibition of brain nitric oxide synthase by 7-nitro indazole","volume":"5","author":"GM MacKenzie","year":"1994","journal-title":"Neuroreport"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuint.2014.10.005","article-title":"Small-molecule inhibitors at the PSD-95\/nNOS interface attenuate MPP+-induced neuronal injury through Sirt3 mediated inhibition of mitochondrial dysfunction","volume":"79","author":"W Hu","year":"2014","journal-title":"Neurochemistry international"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.neuropharm.2015.05.038","article-title":"Small molecule inhibitors of PSD95-nNOS protein-protein interactions as novel analgesics","volume":"97","author":"WH Lee","year":"2015","journal-title":"Neuropharmacology"},{"issue":"2","key":"ref57","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1476-5381.2009.00300.x","article-title":"Disruption of nNOS-PSD95 protein-protein interaction inhibits acute thermal hyperalgesia and chronic mechanical allodynia in rodents","volume":"158","author":"SK Florio","year":"2009","journal-title":"British journal of pharmacology"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pneurobio.2013.11.006","article-title":"Excitotoxicity and stroke: identifying novel targets for neuroprotection","volume":"115","author":"TW Lai","year":"2014","journal-title":"Progress in neurobiology"},{"issue":"19","key":"ref59","doi-asserted-by":"crossref","first-page":"8185","DOI":"10.1523\/JNEUROSCI.4578-12.2013","article-title":"The nNOS-p38MAPK pathway is mediated by NOS1AP during neuronal death","volume":"33","author":"LL Li","year":"2013","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"issue":"40","key":"ref60","doi-asserted-by":"crossref","first-page":"13535","DOI":"10.1523\/JNEUROSCI.1305-14.2014","article-title":"Interaction of nNOS with PSD-95 negatively controls regenerative repair after stroke","volume":"34","author":"CX Luo","year":"2014","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"12157","DOI":"10.1038\/srep12157","article-title":"Biochemical investigations of the mechanism of action of small molecules ZL006 and IC87201 as potential inhibitors of the nNOS-PDZ\/PSD-95-PDZ interactions","volume":"5","author":"A Bach","year":"2015","journal-title":"Scientific reports"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0182698","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T19:40:50Z","timestamp":1659296450000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0182698"}},"subtitle":[],"editor":[{"given":"David A","family":"Slattery","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,3]]},"references-count":61,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0182698","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,3]]}}}